Skip to main content

VIEMED HEALTHCARE, INC.

For the period ended Jun 30, 2026. Filed Aug 3, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2026 · Filed Aug 3, 2026

VMD$8.95-2.0%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Statements of Changes in Shareholders' Equity

VIEMED HEALTHCARE, INC.CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN SHAREHOLDERS' EQUITY

(Expressed in thousands of U.S. Dollars, except share and per share amounts)(Unaudited)

Common Stock · Additional paid-in capital · Noncontrolling interest in subsidiary · Total Shareholders'equity
Shares · Amount · Retained earnings
Shareholders' equity, December 31, 202439,132,897$23,365$18,337$89,691$1,908$133,301
Stock-based compensation - options——16——16
Stock-based compensation - restricted stock——2,295——2,295
Exercise of options2,22511———11
Shares issued for vesting of restricted stock units581,8384,775(4,775)———
Shares redeemed to pay income tax(193,173)——(1,584)—(1,584)
Net income———2,625852,710
Shareholders' equity, March 31, 202539,523,787$28,151$15,873$90,732$1,993$136,749
Stock-based compensation - options——6——6
Stock-based compensation - restricted stock——2,335——2,335
Exercise of options336,6331,357———1,357
Shares issued for vesting of restricted stock units21,293145(145)———
Shares redeemed to pay income tax(6,647)——(47)—(47)
Distribution to non-controlling interest————(193)(193)
Share repurchases(270,061)(1,866)33——(1,833)
Net income———3,157933,250
Shareholders' equity, June 30, 202539,605,005$27,787$18,102$93,842$1,893$141,624
Common Stock · Additional paid-in capital · Noncontrolling interest in subsidiary · Total Shareholders'equity
Shares · Amount · Retained earnings
Shareholders' equity, December 31, 202538,019,082$16,912$21,742$102,891$1,976$143,521
Stock-based compensation - restricted stock——2,451——2,451
Exercise of options80,955526———526
Shares issued for vesting of restricted stock units851,5516,343(6,343)———
Shares redeemed to pay income tax(268,002)(1,996)———(1,996)
Distribution to non-controlling interest————(174)(174)
Share repurchases(150,000)(974)(271)——(1,245)
Net income———2,5821312,713
Shareholders' equity, March 31, 202638,533,586$20,811$17,579$105,473$1,933$145,796
Stock-based compensation - restricted stock——2,032——2,032
Exercise of options76,642531———531
Shares issued for vesting of restricted stock units13,260126(126)———
Shares redeemed to pay income tax(4,458)(42)———(42)
Distribution to non-controlling interest————(133)(133)
Share repurchases(530,802)(3,445)(1,675)——(5,120)
Net income———2,7641362,900
Shareholders' equity, June 30, 202638,088,228$17,981$17,810$108,237$1,936$145,964

See accompanying notes to the condensed consolidated financial statements

Page 5

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.